G. Bradley Cole - 29 Jul 2026 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Reporting relationship
Director
Issuer ticker
KNSA
Reported as of
29 Jul 2026
Net transaction value
-$299,092
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Jul 2026, 16:34:49 UTC
Prior SEC filing
02 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Barry, Attorney-in-Fact

Key filing fact

G. Bradley Cole filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 31 Jul 2026.

Key facts

  • This page summarizes G. Bradley Cole's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Jul 2026, 16:34.

Change

  • Previous filing in this sequence was filed on 02 Jun 2026.
  • Current net transaction value: -$299,092.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001337798 Primary reporting owner

Cole G Bradley

Relationship
Director
Address
C/O KINIKSA PHARMACEUTICALS INT'L, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM
Signature
/s/ Douglas Barry, Attorney-in-Fact
Signature date
31 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Sale

Transaction value
$299,092
Shares
-3,673
Change %
-24%
Price
$81.43
Shares after
11,672
Date
29 Jul 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Gift

Transaction value
Shares
-4,500
Change %
-39%
Price
$0.000000*
Shares after
7,172
Date
29 Jul 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .